Skip to main content
. 2019 Jan 31;2019(1):CD012621. doi: 10.1002/14651858.CD012621.pub2

Comparison 5. Group 3 Pulmonary Hypertension due to lung disease.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Improvement in WHO functional class 1   Odds Ratio (M‐H, Fixed, 95% CI) Totals not selected
2 Six‐minute walk distance 5 350 Mean Difference (Random, 95% CI) 26.70 [2.00, 51.39]
3 QOL 2 238 Mean Difference (Random, 95% CI) 0.19 [‐0.07, 0.44]
4 mean PAP 2 61 Mean Difference (Fixed, 95% CI) ‐0.14 [‐6.65, 6.37]
5 Cardiac Index 1   Mean Difference (Fixed, 95% CI) Totals not selected
6 PVR 1   Mean Difference (Fixed, 95% CI) Totals not selected
7 RAP 1   Mean Difference (Fixed, 95% CI) Totals not selected